Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Development and Evaluation of an NTM-IGRA to Guide Pediatric Lymphadenitis Diagnosis

  • Villar-Hernández, Raquel|||0000-0002-2249-0579
  • Latorre, Irene|||0000-0001-8159-2455
  • Noguera-Julian, Antoni|||0000-0001-7485-0583
  • Martínez-Planas, Aina
  • Minguell Domingo, Laura
  • Vallmanya, Teresa
  • Méndez Hernández, Maria|||0000-0001-5697-2763
  • Soriano-Arandes, Antoni|||0000-0001-9613-7228
  • Baquero-Artigao, Fernando|||0000-0002-6903-3826
  • Rodríguez-Molino, Paula
  • Guillén-Martín, Sara
  • Toro Rueda, Carlos
  • De Souza Galvão, Maria Luiza|||0000-0001-9703-989X
  • Jiménez-Fuentes, María Ángeles|||0000-0001-5181-4192
  • Stojanovic, Zoran|||0000-0001-5082-0750
  • Sabriá, Josefina
  • Santos, José Ramón|||0000-0002-0886-7114
  • Puig, Jordi|||0000-0002-4075-0346
  • Domínguez-Álvarez, Marisol
  • Millet, Joan Pau|||0000-0003-0200-2459
  • Altet, Neus
  • Galea, Yolanda
  • Muriel-Moreno, Beatriz|||0000-0002-6683-9082
  • García-García, Esther
  • Bach Griera, Marc|||0000-0001-9845-7225
  • Prat i Aymerich, Cristina|||0000-0001-6974-9165
  • Julián, Esther|||0000-0002-6558-3978
  • Torrelles, Jordi B.|||0000-0001-7702-5941
  • Rodrigo Gonzalo de Líria, Carlos|||0000-0003-1140-2585
  • Domínguez, José|||0000-0001-7888-0309
Background: Diagnosis of nontuberculous mycobacteria (NTM) infections remains a challenge. In this study, we describe the evaluation of an immunological NTM-interferon (IFN)-γ release assay (IGRA) that we developed using glycopeptidolipids (GPLs) as NTM-specific antigens. Methods: We tested the NTM-IGRA in 99 samples from pediatric patients. Seventy-five were patients with lymphadenitis: 25 were NTM confirmed, 45 were of unknown etiology but compatible with mycobacterial infection and 5 had lymphadenitis caused by an etiologic agent other than NTM. The remaining 24 samples were from control individuals without lymphadenitis (latently infected with M.Tuberculosis, uninfected controls and active tuberculosis patients). Peripheral blood mononuclear cells were stimulated overnight with GPLs. Detection of IFN-γ producing cells was evaluated by enzyme-linked immunospot assay. Results: NTM culture-confirmed lymphadenitis patient samples had a significantly higher response to GPLs than the patients with lymphadenitis of unknown etiology but compatible with mycobacterial infection (P < 0.001) and lymphadenitis not caused by NTM (P < 0.01). We analyzed the response against GPLs in samples from unknown etiology lymphadenitis but compatible with mycobacterial infection cases according to the tuberculin skin test (TST) response, and although not statistically significant, those with a TST ≥5 mm had a higher response to GPLs when compared with the TST <5 mm group. Conclusions: Stimulation with GPLs yielded promising results in detecting NTM infection in pediatric patients with lymphadenitis. Our results indicate that the test could be useful to guide the diagnosis of pediatric lymphadenitis. This new NTM-IGRA could improve the clinical handling of NTM-infected patients and avoid unnecessary misdiagnosis and treatments.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Matryoshka-type gastro-resistant microparticles for the oral treatment of Mycobacterium tuberculosis

  • Andreu, Vanesa
  • Larrea, Ane
  • Rodriguez-Fernandez, Pablo
  • Alfaro, Salvador
  • Gracia, Begoña
  • Lucía, Ainhoa
  • Usón, Laura
  • Gómez, Andromeda-Celeste
  • Mendoza, Gracia
  • Lacoma, Alicia
  • Domínguez, José
  • Prat, Cristina
  • Sebastián, Victor
  • Ainsa, José Antonio
  • Arruebo, Manuel
Aim: Production of Matryoshka-type gastroresistant microparticles containing antibiotic-loaded poly lactic-co-glycolic acid (PLGA) nanoparticles (NP) against Mycobacterium tuberculosis. Materials & methods: The emulsification and evaporation methods were followed for the synthesis of PLGA–NPs and methacrylic acid-ethyl acrylate-based coatings to protect rifampicin from degradation under simulated gastric conditions. Results & conclusion: The inner antibiotic-loaded NPs here reported can be released under simulated intestinal conditions whereas their coating protects them from degradation under simulated gastric conditions. The encapsulation does not hinder the antituberculosis action of the encapsulated antibiotic rifampicin. A sustained antibiotic release could be obtained when using the drug-loaded encapsulated NPs. Compared with the administration of the free drug, a more effective elimination of M. tuberculosis was observed when applying the NPs against infected macrophages. The antibiotic-loaded PLGA–NPs were also able to cross an in vitro model of intestinal barrier. Matryoshka-type gastroresistant microparticles containing antibiotic-loaded poly lactic-co-glycolic acid nanoparticles against M. tuberculosis were produced to protect the antibiotic from degradation under simulated gastric conditions. The antibiotic-loaded poly lactic-co-glycolic acid nanoparticles were able to cross an in vitro model of intestinal barrier, being more effective in the elimination of M. tuberculosis when applied against infected macrophages compared with the use of the free drug.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Assessment of the influence of direct tobacco smoke on infection and active TB management

  • Altet, Neus
  • Latorre, Irene|||0000-0001-8159-2455
  • Jiménez-Fuentes, María Ángeles|||0000-0001-5181-4192
  • Maldonado, José
  • Molina Romero, Israel|||0000-0001-6642-7515
  • González-Díaz, Yoel
  • Milà, Celia
  • García-García, Esther
  • Muriel-Moreno, Beatriz|||0000-0002-6683-9082
  • Villar-Hernández, Raquel|||0000-0002-2249-0579
  • Laabei, Maisem|||0000-0002-8425-3704
  • Gómez, Andromeda-Celeste|||0000-0002-0075-6903
  • Godoy, Pere|||0000-0002-2896-7286
  • De Souza Galvão, Maria Luiza|||0000-0001-9703-989X
  • Solano Reina, Segismundo
  • Jiménez-Ruiz, Carlos A.
  • Domínguez, José|||0000-0001-7888-0309
Background. Smoking is a risk factor for tuberculosis (TB) infection and disease progression. Tobacco smoking increases susceptibility to TB in a variety of ways, one of which is due to a reduction of the IFN-γ response. Consequently, an impaired immune response could affect performance of IFN-γ Release Assays (IGRAs). Objective. In the present study, we assess the impact of direct tobacco smoking on radiological manifestations, sputum conversion and immune response to Mycobacterium tuberculosis, analyzing IFN-γ secretion by IGRAs. Methods. A total of 525 participants were studied: (i) 175 active pulmonary TB patients and (ii) 350 individuals coming from contact tracing studies, 41 of whom were secondary TB cases. Clinical, radiological and microbiological data were collected. T-SPOT.TB and QFN-G-IT were processed according manufacturer's instructions. Results. In smoking patients with active TB, QFN-G-IT (34.4%) and T-SPOT.TB (19.5%) had high frequencies of negative results. In addition, by means of an unconditional logistic regression,smoking was a main factor associated with IGRAs' false-negative results (aOR: 3.35; 95% CI:1.47±7.61; p<0.05). Smoking patients with active TB presented a high probability of having cavitary lesions (aOR: 1.88; 95%CI:1.02±3.46;p<0.05). Mean culture negativization (months) ± standard deviation (SD) was higher in smokers than in non-smokers (2.47±1.3 versus 1.69±1.4). Latent TB infection (LTBI) was favored in smoking contacts, being a risk factor associated with infection (aOR: 11.57; 95%CI:5.97±22.41; p<0.00005). The IFN-γ response was significantly higher in non-smokers than in smokers. Smoking quantity and IFN-γ response analyzed by IGRAs were dose-dependent related. Conclusions. Smoking had a negative effect on radiological manifestations, delaying time of sputum conversion. Our data establish a link between tobacco smoking and TB due to a weakened IFN- γ response caused by direct tobacco smoke.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Immune-mediated inflammatory diseases differently affect IGRAs' accuracy for latent tuberculosis infection diagnosis in clinical practice

  • Latorre, Irene|||0000-0001-8159-2455
  • Mínguez, Sonia
  • Carrascosa, José Manuel|||0000-0003-4266-0771
  • Naves, Juan Enrique
  • Villar-Hernández, Raquel|||0000-0002-2249-0579
  • Muriel-Moreno, Beatriz|||0000-0002-6683-9082
  • Prat i Aymerich, Cristina|||0000-0001-6974-9165
  • García-García, Esther
  • Casas, Irma|||0000-0002-5902-5777
  • Domènech, Eugeni|||0000-0002-2315-7196
  • Ferrándiz, Carlos|||0000-0001-9030-8399
  • Mateo, Lourdes|||0000-0002-6394-2949
  • Domínguez, José|||0000-0001-7888-0309
Background. Clinical accuracy of IGRAs remains unclear on patients with immune-mediated inflammatory diseases (IMIDs). Here, we assess the impact of immunosuppressants and IMIDs on QuantiFERON-TB Gold In-Tube (QFN-G-IT) and T-SPOT.TB accuracy. Methods. Patients with IMIDs who required latent tuberculosis infection (LTBI) screening were enrolled and classified into: (i) 50 patients with inflammatory rheumatic diseases, (ii) 50 patients with psoriasis and (iii) 30 patients with Crohn's disease. A total of 44 healthy individuals without immunosuppression were also included as controls. Tuberculin skin test (TST), T-SPOT.TB and QFN-G-IT assays were performed. IGRAs were performed following manufacturer's instructions. Results. Immunosuppressant's intake was more frequent on patients with Crohn's disease and psoriasis. Positive IGRAs and TST results were reduced in Crohn's disease patients, whereas rate of indeterminate T-SPOT.TB results was increased in this group with respect to the other IMIDs analysed and controls. When IFN-γ response was studied, the levels of this cytokine after mitogen stimulation were significantly lower in Crohn's and inflammatoryrheumatic diseases than in psoriasis. Interestingly, psoriatic patients were the only ones not receiving corticosteroids. Furthermore, a negative correlation was observed between the IFN-γ secreted after mitogen stimulation and corticosteroids dose. Conclusions. IMIDs seem to negatively affect the clinical accuracy of IGRAs, being Crohn's disease patients the most affected individuals due to their concomitant drug-profile and impaired immune response.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Study of CD27 and CCR4 markers on specific CD4+ T-cells as immune tools for active and latent tuberculosis management

  • Latorre, Irene|||0000-0001-8159-2455
  • Fernández Sanmartin, Marco Antonio
  • Muriel-Moreno, Beatriz|||0000-0002-6683-9082
  • Villar-Hernández, Raquel|||0000-0002-2249-0579
  • Vila, Sergi
  • De Souza Galvão, Maria Luiza|||0000-0001-9703-989X
  • Stojanovic, Zoran|||0000-0001-5082-0750
  • Jiménez-Fuentes, María Ángeles|||0000-0001-5181-4192
  • Centeno, Carmen
  • Ruiz Manzano, Juan|||0000-0001-7213-7346
  • Millet, Joan Pau|||0000-0003-0200-2459
  • Molina-Pinargote, Israel|||0000-0002-9160-0284
  • González, Yoel-Domingo|||0000-0002-5991-8938
  • Lacoma, Alicia|||0000-0002-2049-3872
  • Luque-Chacón, Lydia
  • Sabriá, Josefina
  • Prat i Aymerich, Cristina|||0000-0001-6974-9165
  • Domínguez, José|||0000-0001-7888-0309
The immunological characterization of different cell markers has opened the possibility of considering them as immune tools for tuberculosis (TB) management, as they could correlate with TB latency/disease status and outcome. CD4+ T-cells producing IFN-γ+ with a low expression of CD27 have been described as an active TB marker. In addition, there are unknown homing receptors related to TB, such as CCR4, which might be useful for understanding TB pathogenesis. The aim of our study is focused on the assessment of several T-cell subsets to understand immune-mechanisms in TB. This phenotypic immune characterization is based on the study of the specific immune responses of T-cells expressing CD27 and/or CCR4 homing markers. Subjects enrolled in the study were: (i) 22 adult patients with active TB, and (ii) 26 individuals with latent TB infection (LTBI). Blood samples were drawn from each patient. The expression of CD27 and/or CCR4 markers were analyzed within CD4+ T-cells producing: (i) IFN-γ+, (ii) TNF-α+, (iii) TNF-α+IFN-γ+, and (iv) IFN-γ+ and/or TNF-α+. The percentage of CD27. within all CD4+ T-cell populations analyzed was significantly higher on active TB compared to LTBI after PPD or ESAT-6/CFP-10 stimulation. As previously reported, a ratio based on the CD27 median fluorescence intensity (MFI) was also explored (MFI of CD27 in CD4+ T-cells over MFI of CD27 in IFN-γ+CD4+ T-cells), being significantly increased during disease (p < 0.0001 after PPD or ESAT-6/CFP-10 stimulation). This ratio was also assessed on the other CD4+ T-cells functional profiles after specific stimulation, being significantly associated with active TB. Highest diagnostic accuracies for active TB (AUC ≥ 0.91) were achieved for: (i) CD27 within IFN-γ+TNF-α+CD4+ T-cells in response to ESAT-6/CFP-10, (ii) CD27 and CCR4 markers together within IFN-γ+CD4+ T-cells in response to PPD, and (iii) CD27 MFI ratio performed on IFN-γ+TNF-α+CD4+ T-cells after ESAT-6/CFP-10 stimulation. The lowest diagnostic accuracy was observed when CCR4 marker was evaluated alone (AUC ≤ 0.77). CD27 and CCR4 expression detection could serve as a good method for immunodiagnosis. Moreover, the immunological characterization of markers/subset populations could be a promising tool for understanding the biological basis of the disease.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Use of IP-10 detection in dried plasma spots for latent tuberculosis infection diagnosis in contacts via mail

  • Villar-Hernández, Raquel|||0000-0002-2249-0579
  • Latorre, Irene|||0000-0001-8159-2455
  • De Souza Galvão, Maria Luiza|||0000-0001-9703-989X
  • Jiménez, María A.
  • Ruiz Manzano, Juan|||0000-0001-7213-7346
  • Pilarte, Jose
  • García-García, Esther
  • Muriel-Moreno, Beatriz|||0000-0002-6683-9082
  • Cantos, Adela
  • Altet, Neus
  • Millet, Joan Pau|||0000-0003-0200-2459
  • González, Yoel-Domingo|||0000-0002-5991-8938
  • Molina-Pinargote, Israel|||0000-0002-9160-0284
  • Prat i Aymerich, Cristina|||0000-0001-6974-9165
  • Ruhwald, Morten|||0000-0002-1597-441X
  • Domínguez, José|||0000-0001-7888-0309
The aim of this study was to test the use of IP-10 detection in dried plasma from contact studies individuals (contacts of smear positive patients), by comparing it with IP-10 and IFN-γ detection in direct plasma, to establish IP-10 detection in DPS as a useful assay for LTBI diagnosis. Whole blood samples were collected from 80 subjects: 12 with active tuberculosis (TB), and 68 from contact studies. The amount of IFN-γ produced by sensitized T cells was determined in direct plasma by QuantiFERON Gold In-Tube test. IP-10 levels were determined in direct and dried plasma by an in-house ELISA. For dried plasma IP-10 determination, two 25 µl plasma drops were dried in Whatman903 filter paper and sent by mail to the laboratory. Regarding TB patients, 100.0%, 91.7% and 75.0% were positive for IFN-γ detection and IP-10 detection in direct and dried plasma, respectively. In contacts, 69.1%, 60.3% and 48.5% had positive results after IFN-γ and IP-10 in direct and dried plasma, respectively. The agreement among in vitro tests was substantial and IP-10 levels in direct and dried plasma were strongly correlated (r = 0.897). In conclusion, IP-10 detection in dried plasma is a simple and safe method that would help improve LTBI management.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Genetic characterization of Mycobacterium tuberculosis complex isolates circulating in Abuja, Nigeria

  • Molina-Moya, Barbara|||0000-0001-5144-2165
  • Abdurrahman, Saddiq T.
  • Madukaji, Laura I
  • Gomgnimbou, Michel Kiréopori
  • Spinasse, Lizania|||0000-0001-6286-518X
  • Gomes Fernandes, Meissiner|||0000-0002-9454-8848
  • Gomes, Harrison Magdinier
  • Kacimi, Sarah
  • Dacombe, Russell|||0000-0002-6705-1537
  • Bimba, John|||0000-0001-7847-4271
  • Lawson, Lovett
  • Sola, Christophe|||0000-0003-4672-2140
  • Cuevas, Luis E..|||0000-0002-6581-0587
  • Domínguez, José|||0000-0001-7888-0309
Nigeria ranks fourth among the high tuberculosis (TB) burden countries. This study describes the prevalence of drug resistance and the genetic diversity of Mycobacterium tuberculosis in Abuja's Federal Capital Territory. Two hundred and seventy-eight consecutive sputum samples were collected from adults with presumptive TB during 2013-2014. DNA was extracted from Löwenstein-Jensen cultures and analyzed for the identification of nontuberculous mycobacteria species, detection of drug resistance with line probe assays, and high-throughput spacer oligonucleotide typing (spoligotyping) using microbead-based hybridization. Two hundred and two cultures were positive for M. tuberculosis complex, 24 negative, 38 contaminated, and 15 positive for nontuberculous mycobacteria. Five (2.5%) M. tuberculosis complex isolates were resistant to rifampicin (RIF) and isoniazid (multidrug resistant), nine (4.5%) to RIF alone, and 15 (7.4%) to isoniazid alone; two RIF-resistant isolates were also resistant to fluoroquinolones and ethambutol, and one multidrug resistant isolate was also resistant to ethambutol. Among the 180 isolates with spoligotyping results, 164 (91.1%) were classified as lineage 4 (Euro-American), 13 (7.2%) as lineage 5 (West African 1), two (1.1%) as lineage 2 (East Asia), and one (0.6%) as lineage 6 (West African 2). One hundred and fifty-six (86.7%) isolates were grouped in 17 clusters (2-108 isolates/cluster), of which 108 (60.0%) were grouped as L4.6.2/Cameroon (spoligotype international type 61). The description of drug resistance prevalence and genetic diversity of M. tuberculosis in this study may be useful for improving TB control in Nigeria.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Serial testing of health care workers for tuberculosis infection, A prospective cohort study

  • Casas, Irma|||0000-0002-5902-5777
  • Esteve Pardo, Ma. Guadalupe
  • Guerola, Rosa
  • Latorre, Irene|||0000-0001-8159-2455
  • Villar-Hernández, Raquel|||0000-0002-2249-0579
  • Mena, Guillermo
  • Prat i Aymerich, Cristina|||0000-0001-6974-9165
  • Matllo, Joan
  • Domínguez, José|||0000-0001-7888-0309
Health Care Workers (HCW) may have an occupational risk of latent tuberculosis infection (LTBI) and TB disease. The objective of this study was to evaluate the performance of the 2-step strategy: tuberculin skin test (TST) followed by confirmation with Interferon (IFN)-γ- release assays (IGRAs) in HCW. A secondary objective was to determine the factors related to conversions and reversions. HCW at risk of occupational exposure who attended the Occupational Department of the Hospital Germans Trias i Pujol were included during the study period (2013-2016). All professionals testing negative for LTBI were included in a cohort study. These workers were followed up with the administration of a TST and an IGRA quantification at least one year after inclusion in the study. Workers with positive TST, regardless of the results of the IGRA tests, were followed-up with an IGRA. 255 workers were enrolled in the study and 108 workers from the same cohort were followed up. During the follow-up period, seven workers presented TST test conversion. One of these conversions was also confirmed by an IGRA test. There were 2 conversions of cases only testing positive with the IGRA. There have been only 2 reversions of cases testing negative with the IGRA. In this study, not all TST conversions were confirmed when using the IGRA test, which highlights the importance of the 2-step strategy. We have detected a low number of conversions and reversions. Our conclusions should be confirmed in studies with a longer follow-up time.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Discovery and validation of an NMR-based metabolomic profile in urine as TB biomarker

  • Izquierdo-Garcia, José Luis
  • Comella-del-Barrio, Patricia|||0000-0002-2433-9864
  • Campos-Olivas, Ramón|||0000-0002-5743-2221
  • Villar-Hernández, Raquel|||0000-0002-2249-0579
  • Prat i Aymerich, Cristina|||0000-0001-6974-9165
  • De Souza Galvão, Maria Luiza|||0000-0001-9703-989X
  • Jiménez-Fuentes, María Ángeles|||0000-0001-5181-4192
  • Ruiz Manzano, Juan|||0000-0001-7213-7346
  • Stojanovic, Zoran|||0000-0001-5082-0750
  • González, Adela
  • Serra-Vidal, Mar
  • García-García, Esther
  • Muriel-Moreno, Beatriz|||0000-0002-6683-9082
  • Millet, Joan Pau|||0000-0003-0200-2459
  • Molina-Pinargote, Israel|||0000-0002-9160-0284
  • Casas, Xavier|||0000-0002-3892-9697
  • Santiago, Javier
  • Sabriá, Fina
  • Martos, Carmen
  • Herzmann, Christian
  • Ruiz-Cabello, Jesús|||0000-0001-8681-5056
  • Domínguez, José|||0000-0001-7888-0309
Despite efforts to improve tuberculosis (TB) detection, limitations in access, quality and timeliness of diagnostic services in low- and middle-income countries are challenging for current TB diagnostics. This study aimed to identify and characterise a metabolic profile of TB in urine by high-field nuclear magnetic resonance (NMR) spectrometry and assess whether the TB metabolic profile is also detected by a low-field benchtop NMR spectrometer. We included 189 patients with tuberculosis, 42 patients with pneumococcal pneumonia, 61 individuals infected with latent tuberculosis and 40 uninfected individuals. We acquired the urine spectra from high and low-field NMR. We characterised a TB metabolic fingerprint from the Principal Component Analysis. We developed a classification model from the Partial Least Squares-Discriminant Analysis and evaluated its performance. We identified a metabolic fingerprint of 31 chemical shift regions assigned to eight metabolites (aminoadipic acid, citrate, creatine, creatinine, glucose, mannitol, phenylalanine, and hippurate). The model developed using low-field NMR urine spectra correctly classified 87.32%, 85.21% and 100% of the TB patients compared to pneumococcal pneumonia patients, LTBI and uninfected individuals, respectively. The model validation correctly classified 84.10% of the TB patients. We have identified and characterised a metabolic profile of TB in urine from a high-field NMR spectrometer and have also detected it using a low-field benchtop NMR spectrometer. The models developed from the metabolic profile of TB identified by both NMR technologies were able to discriminate TB patients from the rest of the study groups and the results were not influenced by anti-TB treatment or TB location. This provides a new approach in the search for possible biomarkers for the diagnosis of TB.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Tobacco Smoking and Second-Hand Smoke Exposure Impact on Tuberculosis in Children

  • Altet, Neus
  • Latorre, Irene|||0000-0001-8159-2455
  • Jiménez-Fuentes, María Ángeles|||0000-0001-5181-4192
  • Soriano-Arandes, Antoni|||0000-0001-9613-7228
  • Villar-Hernández, Raquel|||0000-0002-2249-0579
  • Milà, Celia
  • Rodríguez-Fernández, Pablo|||0000-0003-1273-0548
  • Muriel-Moreno, Beatriz|||0000-0002-6683-9082
  • Comella-del-Barrio, Patricia|||0000-0002-2433-9864
  • Godoy, Pere|||0000-0002-2896-7286
  • Millet, Joan Pau|||0000-0003-0200-2459
  • De Souza Galvão, Maria Luiza|||0000-0001-9703-989X
  • Jiménez-Ruiz, Carlos A.
  • Domínguez, José|||0000-0001-7888-0309
Little is known about whether second-hand smoke (SHS) exposure affects tuberculosis (TB). Here, we investigate the association of cigarette smoke exposure with active TB and latent TB infection (LTBI) in children, analyzing Interferon-Gamma Release Assays' (IGRAs) performance and cytokine immune responses. A total of 616 children from contact-tracing studies were included and classified regarding their smoking habits [unexposed, SHS, or smokers]. Risk factors for positive IGRAs, LTBI, and active TB were defined. GM-CSF, IFN-γ, IL-2, IL-5, IL-10, IL-13, IL-22, IL-17, TNF-α, IL-1RA and IP-10 cytokines were detected in a subgroup of patients. Being SHS exposed was associated with a positive IGRA [aOR (95% CI): 8.7 (5.9-12.8)] and was a main factor related with LTBI [aOR (95% CI): 7.57 (4.79-11.94)] and active TB [aOR (95% CI): 3.40 (1.45-7.98)]. Moreover, IGRAs' sensitivity was reduced in active TB patients exposed to tobacco. IL-22, GM-CSF, IL-5, TNF-α, IP-10, and IL-13 were less secreted in LTBI children exposed to SHS. In conclusion, SHS is associated with LTBI and active TB in children. In addition, false-negative IGRAs obtained on active TB patients exposed to SHS, together with the decrease of specific cytokines released, suggest that tobacco may alter the immune response.